Skip to content

Znomics, Inc.

company.status.inactive

CIK 1371473fmd_1P1VTE8GYF3HE6BT3YXZ05H0MNManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2010 to Sep 30, 2013, 15 periods

Income Statement · Annual · Millions · USD
Line itemFY2010FY2011FY2012
Selling, general and administrative000
Total operating expenses00–
Operating income(0)(0)(0)
Interest expense–00
Other non-operating income (expense)–(0)0
Income tax expense–00
Net income(0)(0)(0)
Net income to common shareholders–(60)(45)
Znomics, Inc. financial statements · FinancialMD